PAVmed Series Z Warrant PAVMZ 深 沪
等待开盘 08-20 09:30:00 美东时间
0.0009
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.0009
- 总市值 1.20万
- 52周最高 0.072
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.0008
- 委 比 0.00%
- 总股本 1334.31万
- 历史最高 8.07
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.0008
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PAVmed Q2 Adj. EPS $(0.05) Beats $(0.13) Estimate, Sales $6.000K Miss $10.000K Estimate
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 94.05 percent increase over losses of $(0.84) per share from the same
08-14 20:01
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
PAVmed gets 180-day extension to regain Nasdaq listing compliance
PAVmed (NASDAQ:PAVM) has been granted a 180-day extension to regain compliance with the $1.00 minimum bid price requirement under the Nasdaq listing rule. The company now has until January 19, 2026 to...
07-30 20:16
Preview: Ekso Bionics Holdings's Earnings
Ekso Bionics Holdings (NASDAQ:EKSO) is set to give its latest quarterly earning...
07-26 03:01
Lucid Diagnostics, a PAVmed Subsidiary, Nears Medicare Decision on EsoGuard Cancer Test
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that on
07-16 19:35
PAVmed’s Veris Health Completes $2.5M Offering
An announcement from PAVmed ( ($PAVM) ) is now available. On June 23, 2025, Ver...
06-24 20:46
PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing
Private placement yields $2.5 million from the sale of Veris Health common stock at a $35 million pre-money valuation. NEW YORK, June 24, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PA...
06-24 20:01
Ascendiant Capital Maintains Buy on PAVmed, Lowers Price Target to $19
Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and lowers the price target from $19.5 to $19.
06-06 18:29
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes
NEW YORK, May 27, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
05-27 19:31
PAVmed shares are trading lower after the company reported a year-over-year decrease in Q1 sales results.
PAVmed shares are trading lower after the company reported a year-over-year dec...
05-15 23:51
